(HALO) Halozyme Therapeutics - Performance 4.7% in 12m
HALO performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
40.70%
#12 in Peer-Group
Rel. Strength
43.04%
#4372 in Stock-Universe
Total Return 12m
4.73%
#62 in Peer-Group
Total Return 5y
92.93%
#16 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 13.8 |
| P/E Forward | 11.0 |
| High / Low | USD |
|---|---|
| 52 Week High | 70.14 USD |
| 52 Week Low | 42.57 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 46.49 |
| Buy/Sell Signal +-5 | 0.77 |
| Support / Resistance | Levels |
|---|---|
| Support | 54.0, 52.0, 48.8, 45.6 |
| Resistance | 61.0, 57.8 |
12m Total Return: HALO (4.7%) vs XBI (-7%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
3.23% | 73% | 77.8% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-9.1% | -6.38% | 147% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
3.91% | -0.97% | 36% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
1.34% | 27.6% | -4.82% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.69% | -7.17% | 1.14% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
18.3% | 43% | -4.19% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.03% | 58.7% | -9.25% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
6.2% | 28.7% | 15.2% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: HALO vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for HALO
| Total Return (including Dividends) | HALO | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 0.28% | 3.36% | 5.25% |
| 3 Months | -9.65% | 15.73% | 24.13% |
| 12 Months | 4.73% | -7.02% | 14.15% |
| 5 Years | 92.93% | -24.21% | 111.83% |
| Trend Score (consistency of price movement) | HALO | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -48% | 4.4% | 81% |
| 3 Months | -70.8% | 78.8% | 96.9% |
| 12 Months | 7.3% | -85.8% | 44.9% |
| 5 Years | 50.4% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th51.50 | -2.98% | -4.72% |
| 3 Month | %th19.50 | -21.93% | -27.22% |
| 12 Month | %th69.50 | 12.65% | -8.25% |
| 5 Years | %th93.50 | 154.55% | -8.92% |
FAQs
Does Halozyme Therapeutics (HALO) outperform the market?
Yes,
over the last 12 months HALO made 4.73%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.02%.
Over the last 3 months HALO made -9.65%, while XBI made 15.73%.
Performance Comparison HALO vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
HALO vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 1.7% | -5% | 1.3% | -9% |
| US NASDAQ 100 | QQQ | 2% | -5% | 0.6% | -8% |
| German DAX 40 | DAX | 3.9% | 1.7% | -10.9% | -24% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 1.9% | -3% | -2.2% | -15% |
| Hongkong Hang Seng | HSI | 2.1% | -5.8% | -18.2% | -34% |
| India NIFTY 50 | INDA | 3.6% | -3.2% | 0.9% | 6% |
| Brasil Bovespa | EWZ | -0.7% | -8.5% | -23.8% | -5% |
HALO vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 3.1% | -5.6% | -2.9% | -20% |
| Consumer Discretionary | XLY | 2.2% | -2.9% | 8.9% | -13% |
| Consumer Staples | XLP | 1.4% | -0.4% | -0.4% | -4% |
| Energy | XLE | 1.4% | -6.8% | 5.4% | 5% |
| Financial | XLF | 1% | -4.8% | -3.7% | -25% |
| Health Care | XLV | 2.3% | -1.9% | 8.6% | 9% |
| Industrial | XLI | 1.6% | -3.9% | -6.6% | -20% |
| Materials | XLB | -0.5% | -4% | -3.3% | -1% |
| Real Estate | XLRE | 1.8% | -0.7% | 1.5% | -8% |
| Technology | XLK | 1% | -8.4% | -1.1% | -6% |
| Utilities | XLU | 2.8% | -1.5% | -2% | -18% |
| Aerospace & Defense | XAR | 3.9% | -6.8% | -17.3% | -45% |
| Biotech | XBI | 0.7% | -3.1% | 14.5% | 12% |
| Homebuilder | XHB | -0.8% | -6.7% | 8.4% | -1% |
| Retail | XRT | -0.8% | -4.7% | 5.6% | -7% |
HALO vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 0.8% | -8.16% | 9.64% | 12% |
| Natural Gas | UNG | 11.2% | 10.1% | 18% | 7% |
| Gold | GLD | 1.5% | 1.5% | -19.4% | -34% |
| Silver | SLV | 0.7% | -6.6% | -16.1% | -13% |
| Copper | CPER | 2.7% | -4.3% | -15.8% | -6% |
HALO vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 3.5% | -0.8% | 4.7% | 7% |
| iShares High Yield Corp. Bond | HYG | 2.9% | -1.3% | 2.4% | -5% |